Xcout Intel
Owkin
Owkin builds artificial intelligence solutions to automate biopharmaceutical research and development and support clinical research. Its core product, K Pro, is an AI agent that analyzes multimodal patient data to generate insights, inform decision-making, and assist biopharma and healthcare professionals.
Subscribe to see Owkin’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Owkin at a glance
Owkin is an ai/ml company headquartered in France. Xcout recorded 6 job postings from Owkin in the last 90 days, naming tools such as Salesforce.
Hiring at Owkin
Xcout recorded 6 job postings from Owkin in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Owkin's job postings
The weekly hiring trend, the roles and locations behind it — see Owkin's hiring signals →
Tech stack
Owkin competitors
A few of Owkin's closest competitors — see the full list of competitors and alternatives →
Omec.AI is an Israeli startup founded in 2022 and headquartered in Rehovot, Israel, supported by AION Labs. The company is developing an AI-driven computational platform designed to help pharmaceutical researchers assess the clinical trial readiness of drug candidates by analyzing pre-clinical safety and efficacy data.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
GenInvo provides AI-powered software solutions and services designed for clinical trials in the life sciences sector. The company's products automate clinical data anonymization, synthetic data generation, medical writing, and statistical programming to help pharmaceutical, biotechnology, and contract research organizations ensure regulatory compliance.
Pangea Biomed, founded in 2018 and headquartered in Tel Aviv, Israel, is a biotechnology company focused on cancer. Its mission is to democratize precision oncology, bringing deep tumor intelligence to drug development and treatment nomination.
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Get Owkin's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Owkin in Xcout Intel
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access